C erebral vasospasm is a leading cause and a frequent complication of the morbidity and mortality of subarachnoid hemorrhage (SAH). Cerebral vasospasm is characterized by a delayed, prolonged constriction, occurring mainly in vascular smooth muscle cells, 1, 2 and by cell proliferation within the arterial wall. 3 The cause of vasospasm might be vasoactive substances (such as oxyhemoglobin, purine, and pyrimidine nucleotides) released into the subarachnoid space by the dissolution of the resultant blood clot 4, 5 or by vasoactive agents released from the vessel wall (such as endothelin). These spasmogens might produce gene expression changes that lead not only to a prolonged contraction but also to cell differentiation, cell proliferation, and cell death. 3, 6 The P 2 receptor (P 2 nucleotide receptor) was also referred to as P 2 purinergic receptor (purinoceptor) previously. A large number of P 2 receptor subtypes can be divided into 2 major families: the ligand-gated ion channel P 2X receptors and the G protein-coupled P 2Y receptors. More than 7 P 2X and 8 P 2Y subtypes were identified. P 2 receptors play a central role in the functions of extracellular nucleotides in peripheral and central neuronal tissues,
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in the regulation of lung surfactant secretion, and in the regulation of the cardiovascular system. P 2 receptors have been identified in cerebral arteries. Among the many identified P 2 receptor subtypes, P 2X1 , P 2Y1 , and P 2Y2 are the major functional populations expressed in vascular tissues. 7 The P 2X1 receptor exists mainly in smooth muscle cells. Activating P 2X1 induces Ca 2ϩ influx and cerebral arterial contraction. 8 P 2Y1 and P 2Y2 are G protein-coupled receptors. Activating P 2Y receptors leads to increased intracellular Ca 2ϩ , cerebral arterial contraction, 5,9 -12 and vasospasm in animals. 5, 13 The P 2Y1 and P 2Y2 subtypes, in particular among the P 2 receptors, are also involved in mitogenesis via the mitogen-activated protein kinase pathway. 8 Since ATP and P 2 receptors are believed to be involved in vasospasm, we examined the expression of P 2X1 , P 2Y1 , and P 2Y2 , the most frequently expressed and studied P 2 receptors in vascular tissue, in the basilar artery in a rat double hemorrhage model.
Materials and Methods

Rat Double Hemorrhage Model
The protocol for this study complies with the Guide for the Care and Use of Laboratory Animals published by the National Institute of Laboratory Animal Resources (Commission on Life Sciences, National Research Council) and approved by the Institutional Animal Care and Use Committee at the University of Mississippi Medical Center. Thirty Sprague-Dawley male rats (each weighing 350 to 400 g) were anesthetized with an intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg) and were allowed to breathe spontaneously in a supine position. The inguinal region was shaved and prepared in a sterile manner. After we exposed the left femoral artery and prepared to obtain arterial blood by cannulation, a midline incision on the dorsal surface of the neck was made from the cranial vertex to the lower cervical spine. The suboccipital and nuchal muscles were divided bilaterally to expose the atlantooccipital membrane. The rat was then turned over to a supine position again, the blood was drawn, and the rat was placed again in the prone position. With the rat in a prone, head-down position, a 27-gauge needle was inserted into the cisterna magna via an atlanto-occipital membrane puncture. Correct positioning of the needle was determined by successful aspiration of cerebrospinal fluid. After a nonheparinized syringe was used to aspirate 0.3 mL of cerebrospinal fluid, 0.25 to 0.3 mL of autologous arterial blood was withdrawn from the femoral artery and then carefully injected into the cisterna magna over 3 minutes. After injection, the puncture site was immediately sealed with ethyl cyanoacrylate glue. The muscles were sutured layer to layer, and the skin incision was closed. The rats were placed prone in a head-down position at a 30°angle for 20 minutes to ensure rostroventral blood distribution around the basal intracranial arteries. They were kept warm by a heating blanket and monitored closely until they recovered. The day of the first injection was set at day 0. On day 2, the rats received a second injection following the same procedure, but blood was withdrawn from the right femoral artery. One rat from day 3 group died immediately after the second blood injection and was excluded from this study. On days 3, 5, and 7, the rats scheduled for death were euthanatized with an overdose of anesthesia and then decapitated. The basilar arteries were immediately removed under surgical microscope with minimal mechanical manipulation. The vessels were snap-frozen in liquid nitrogen and kept at Ϫ80°C until further analysis. On days 0 and 2, these investigators substituted a sterile 0.9% NaCl solution for blood and administered a double injection to a sham group of 10 rats. The sham rats were killed on day 7. Basilar arteries were collected from a control group of 10 rats that underwent no surgical procedure.
Transmission Electron Microscopy and Imaging Analysis
A separate study of 50 rats using this same double hemorrhage model was also conducted. Two rats died immediately after the second blood injection and were excluded from this study. Rats were euthanatized and killed via left ventricular perfusion of 2% glutaraldehyde-phosphate buffer at physiological blood pressure (100 mm Hg). Basilar arteries were removed and postfixed with 2% glutaraldehyde over a period of 1 week. Ultrathin cross sections of the basilar arteries were stained with uranyl acetate and examined with transmission electron microscopy (TEM). Morphometric determination for lumen perimeter was determined by using a Kodak digital camera and a DigiVision Pro image analysis system (both attached to the LEO 906 TEM). The perimeters of the basilar artery were calculated by imaging analysis. The transverse sections of basilar artery were scanned by a computer and analyzed as a digital image. The perimeter of the vessels was measured by tracing the entire luminal surface of the intima, and the perimeter of the vessels was calculated. The values from each group were expressed as a percentage of the lumen perimeter of control rat basilar artery.
Reverse Transcription and Polymerase Chain Reaction
Total RNA was isolated from rat basilar arteries with the use of RNAzol B. Total RNA was reverse-transcribed to cDNA for use in polymerase chain reaction (PCR). Amplification was performed with the thermal cycler Power Block II (ERICOMP). The thermal cycle profile consisted of denaturation for 1 minute at 92°C, annealing of primers for 1 minute at 56°C, extension for 30 seconds at 72°C, and a final extension step at 72°C for 7 minutes. Reaction conditions and cycle numbers were optimized for each receptor subtype. A relative quantification of the cDNA for each receptor subtype was performed in the logarithmic phase of amplification to obtain a linear relationship between the cycle number and product amplification. An amplification of both the receptor template and an internal control, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), was run in parallel. The PCR primers and their expected product size, as previously reported, 7,14 were as follows: X1 forward (fwd) primer, 5Ј-AGAGGCACTACTACAAGCAGAA-3Ј; X1 reverse (rev) primer, 5Ј-GGTAAGGCTGTGGGAAAGA-3Ј (product size, 434 bp); Y1 fwd primer, 5Ј-CTGCCTGAGTTGGAAAGA-3Ј; Y1 rev primer, 5Ј-TCCCAGTGCCAGAGTAGA-3Ј (663 bp); Y2 fwd primer, 5Ј-ACCCGCACCCTCTATTACT-3Ј; Y2 rev primer, 5Ј-CTTAGATACGATTCCCCAACT-3Ј (538 bp); GAPDH fwd primer, 5Ј-ACCACAGTCCATGCCATCAC-3Ј; GAPDH rev primer, 5Ј-TCCACCACCCTGTTGCTGTA-3Ј (452 bp).
We used a semiquantitative PCR rather than a quantitative PCR. We used the housekeeping gene GAPDH as an internal standard. The aliquots of the reverse transcription (RT) products were used with the same amount of cDNA in PCR with primers for GAPDH and with primers for P 2 subtypes in each sample. Since GAPDH is a housekeeping gene, the intensity of the resulting GAPDH-PCR product should be the same as if we had used an identical amount of cDNA from control and experimental samples. Thus, the difference between ratios for specific gene/GAPDH is due to the change of the specific gene. Consequently, we can estimate the specific gene mRNA change through the change of this ratio. PCR products were electrophoresed in an ethidium bromide-containing 2% agarose gel in Tris-acetate/EDTA buffer. The gels were analyzed with the use of Gel Doc 1000 and Quantity One software (Bio-Rad). We measured the volume of bands of GAPDH and specific genes in each sample. To correct for any variation in RNA content or cDNA synthesis between samples, each sample was normalized according to its GAPDH content. The ratios of the receptor PCR product/GAPDH product were expressed as a percent increase from those of the control. Because the number of samples of rat basilar arteries was small, 3 to 4 samples from each group were pooled for 1 experiment. Three experiments (from 10 different samples) were averaged for calculation. The linear exponential phases for P 2 subtypes and GAPDH PCR were 25 to 36 cycles. Thus, we used 32 cycles for P 2X1 , P 2Y1 , and P 2Y2 and 28 cycles for GAPDH.
Chemicals
RNAzol B was purchased from TEL-TEST, Inc. Superscript II RNase H-RT, oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer, specific primer pairs, and X174RF DNA/HaeIII fragments (marker) were obtained from GIBCO BRL. Amplitaq DNA polymerase, PCR buffer, and dNTPs were obtained from Perkin-Elmer.
Data Analysis
The data were calculated as a ratio of the band volume of target to that of the internal standard and were expressed as meanϮSEM. The statistical analysis was performed with ANOVA followed by Fisher's protected least significant difference test. Differences were considered to be significant at PϽ0.05.
Results
Rat Double Hemorrhage Model
All animals were drowsy on days 1 and 3 after cisternal blood injection but resumed normal behavioral patterns and feeding habits the next day. Gross macroscopic observation/inspection of basilar arteries before removal from the brains revealed blood clots on the basal surface of the brains from Carpenter et al P 2 Receptors and Vasospasm 517 day 3 and 5 samples. The clots were still present but noticeably smaller on samples taken on day 7. Arterial constriction was also observed.
TEM and Imaging Analysis
Histological results showed corrugation of the internal elastic lamina and contraction of smooth muscle cells in basilar arteries. Smooth muscle contraction and corrugation of the internal elastic lamina were most severe on days 5 and 7 ( Figure 1A and 1B) . Imaging analysis demonstrated an overall reduction of the diameter up to 40% in samples collected on days 5 to 7 ( Figure 1C ).
Expression of P 2 Receptors
The expression of P 2X1 receptors decreased significantly (PϽ0.05) on day 3 and increased to the normal range on days 5 through 7 in samples from SAH rats. The expression of P 2Y1 receptors increased significantly (PϽ0.05) on day 5 but decreased to the normal range on day 7. The expression of P 2Y2 receptors increased on day 5 and remained above normal (PϽ0.05) in samples taken on day 7. These results are summarized in Figures 2 and 3 . In all RT-PCRs of these mRNAs, the results from the sham operation group on day 7 were measured at the same level as the control group.
Discussion
The main observations in this study are as follows: (1) double blood injection produced mild to moderate vasospasm on days 5 to 7; (2) mRNA expression of P 2X1 receptors in the basilar arteries from the rats assigned to the SAH injection groups was downregulated on day 3 and recovered on days 5 through 7; (3) mRNA expression of P 2Y1 receptors was upregulated on day 5 and returned to normal on day 7; and (4) mRNA expression of P 2Y2 receptors was upregulated on day 5 and remained above normal on day 7.
Extracellular ATP and Vasospasm
The source of the extracellular nucleotides is a cellular component of subarachnoid blood clots. Millimolar-level concentrations of ATP and ADP are included in erythrocytes, and a high level of UTP is also in platelets. 15 Some experimental data have supported the role of extracellular ATP in vasospasm. ATP induces Ca 2ϩ elevation 9 and contraction 12 of cerebral artery. Even though intraluminal application of ATP produced relaxation, extraluminal application of ATP, a situation that more or less resembles SAH, produced vasoconstriction in cerebral arteries. 16 The removal of ATP by incubating erythrocyte lysate with apyrase (an enzyme that breaks down ATP and ADP into AMP) abolished the action of erythrocyte lysate to elevate Ca 2ϩ . 5 Furthermore, ATP Figure 1 . TEM appearance (A, B) and diameter of basilar arteries (C) in rat double cisternal blood injection model. A, The normal basilar artery has flat endothelial cells and smooth internal elastic lamina. B, On day 7 of SAH, the endothelial cells were deformed, the internal elastic lamina was corrugated, and the smooth muscle cells contracted. Barsϭ5 m. C, When the diameter of control basilar artery was assumed to be 100%, the mean reductions of the diameter of spastic arteries were approximately 30% to 40% on day 3 through day 7. *PϽ0.05 compared with control. nϭ9 in control and day 7 groups; nϭ10 in the other groups.
Figure 2.
Agarose gel (2%) electrophoresis of RT-PCR products of P 2 receptor subtypes mRNA (A, P 2X1 ; B, P 2Y1 ; C, P 2Y2 ) and GAPDH mRNA in the time course of rat double cisternal blood injection model. GAPDH mRNA was amplified at the same time for the internal standard.
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produced vasospasm in rat femoral arteries and in a monkey model of cerebral vasospasm. 5, 13 Contradictory evidence regarding the role of ATP in cerebral vasospasm also exists. First, an ATP-induced contraction is less than that of erythrocyte lysate. 12 Second, the ATP level in the bloody cerebrospinal fluid from a canine double hemorrhage model is measured at the nanomolar level, which is considered to produce no contraction (Yin, MD, PhD, unpublished data, 2000). However, these contradictory data do not rule out possible molecular events (except contractions) involving smooth muscle cells in which a previously high ATP level is required to induce delayed and prolonged vasocontraction.
Differential Expression of P 2 Receptors and Vasospasm
P 2 receptors play an important role in regulating cerebral vascular tone. Even though Ͼ15 P 2 receptor subtypes have been discovered, the most frequently reported P 2 receptors in vascular tissue are the P 2X1 , P 2Y1 , and P 2Y2 subtypes. The P 2X1 receptor is a ligand-gated cation channel that exists mainly in smooth muscle cells and mediates vasoconstriction. 17, 18 The P 2Y1 and P 2Y2 (or P 2U ) subtypes are G protein-coupled receptors. 19 Activation of P 2Y1 receptors, which exist mainly in endothelial cells, leads to vasodilatation. P 2Y1 receptors are also found less frequently in smooth muscle cells. The P 2Y2 receptor is found in endothelial and smooth muscle cells and is responsible for vasodilatation or constriction, respectively. According to You et al, 16, 20 the relaxant effect of P 2Y1 and P 2Y2 receptors is endothelium dependent and is related to the generation of nitric oxide or prostacyclin and endotheliumdependent hyperpolarizing factors. The extracellular nucleotides released from subarachnoid clots are supposed to stimulate all P 2 receptor subtypes in cerebral arteries. Although the pathological roles of P 2 receptors have been implicated in the development of post-SAH cerebral vasospasm, the differential role of each subtype has not been clearly understood. P 2 receptors are involved in contraction or relaxation of cerebral arteries as well as in other cellular functions, such as proliferation and mitogenesis. 8 Differential expression of P 2 receptor subtypes occurs when smooth muscle undergoes phenotypic changes. 7 The P 2X1 Subtype In contractile smooth muscle cells, ␣,␤-methylene-ATP, a potent agonist of P 2X1 receptors, induces a transient increase in intracellular Ca 2ϩ , 21 indicating the expression of P 2X1 receptors. Similarly, a small and sustained P 2X1 receptormediated intracellular Ca 2ϩ elevation was observed in primary cultures of rat aorta smooth muscle cells. 22 However, this P 2X1 receptor-mediated response did not occur in subcultured rat smooth muscle cells, 7, [23] [24] [25] indicating P 2X1 receptor downregulation and phenotypic change. Although P 2X1 contributes to ATP-induced contraction in rat vascular smooth muscle cells, our data suggest that contractile P 2X1 might not be involved in chronic vasospasm: P 2X1 mRNA expression was transiently downregulated on day 3 after double hemorrhage. Postsynaptic P 2X1 downregulation in the arterial wall might also impair the fine neural regulation of cerebrovascular smooth muscle tone. Because the data of mRNA expression were sampled only on days 3, 5, and 7, this study does not rule out a possible role for P 2X1 in "acute vasospasm," which might occur immediately after the blood injection.
The P 2Y1 Subtype P 2Y1 exists mainly in endothelial cells and contributes to endothelium-dependent relaxation. 11, 16, 26 A potent agonist of the P 2Y1 receptor (2 MeS-ATP) induces Ca 2ϩ release in cultured rat smooth muscle cells but not in freshly isolated cells, 23 which indicates an upregulation of P 2Y1 receptors in cultured smooth muscle cells. Because the P 2Y1 receptor is involved in mitogenic effect, the upward regulation of P 2Y1 receptors in culture has also been observed to contribute to an increased progression of cell cycles in smooth muscle cells. 7 Even though P 2Y1 expression in contractile smooth muscle cells was detected, its role was described in cell mitogenesis, and its role in smooth muscle contraction remains to be determined. In this study the mRNA expression of P 2Y1 Figure 3 . Summary of temporal changes in mRNA level of P 2 receptor subtypes (A, P 2X1 ; B, P 2Y2 ; C, P 2Y1 ) in the basilar artery of rat double cisternal blood injection model. Data were described as -fold increases from control and expressed as meanϮSEM, based on the 3 different PCRs taken from 9 to 10 animals in each group (nϭ9 in day 3 group; nϭ10 in the other groups). Marks on the bars show significance (**PϽ0.01, ANOVA followed by Fisher's protected least significant difference test) compared with control.
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transiently upregulated and peaked around day 5. This result might be interpreted as an increase in P 2Y1 mRNA expression in endothelial cells, as an increase in P 2Y1 expression in smooth muscle cells, or as both. Because the nature of multiple layers of smooth muscle cells contrasts with the nature of a thin layer of endothelial cells, we speculate that the altered mRNA P 2Y1 expression might reflect an enhanced expression in smooth muscle cells. Endothelial cells were not removed in this study because it is difficult to remove the endothelium from rat basilar arteries, and the procedure followed in this study required the samples to be frozen immediately after euthanasia to avoid possible decay or contamination of the RNA.
The P 2Y2 Subtype
The mRNA expression of P 2Y2 was upregulated, and the time course of its upregulation was consistent with the time course of cerebral vasospasm. This P 2Y2 upregulation might have led to a contractile response (even to a low concentration of extracellular ATP) and might have contributed to cerebral vasospasm. According to some investigators, P 2Y2 also contributes to mitogenesis 7, 22 by cooperating with other growth factors, such as serum or platelet-derived growth factor. After balloon injury in the endothelium-damaged intimal lesions, the neointimal subpopulation of smooth muscle cells on luminal surface demonstrates a P 2Y2 subtype overexpression. 27 Extracellular ATP also regulates this P 2Y2 -specific upregulation process through the mitogen-activated protein kinase pathway 28 and plays an important role in atherosclerotic intimal hyperplasia. Thus, P 2Y2 mRNA upregulation might be involved in spastic arterial mitogenesis. In a recent article outlining the P 2 receptor subtype changes that occurred during the switching of smooth muscle phenotypes, P 2X1 and P 2Y1 were expressed in freshly isolated rat aortas. If rat aortic smooth muscle cells were cultured, however, the P 2X1 subtype disappeared, and P 2Y1 and P 2Y2 were overexpressed. 7 However, in this rat model the endothelial cells did not detach markedly, nor did subintimal cells proliferate. It is speculated that the upregulation of P 2Y2 receptor in this study might be related to the long-term contractile response of the basilar artery instead of tissue proliferation. The cause of the upregulation of P 2Y2 receptor in smooth muscle cells undergoing cerebral vasospasm is unclear. The most likely cause is blood clot and its lysate (such as erythrocyte lysate, hemoglobin, ATP, and their degenerative products). Perhaps these spasmogens directly or indirectly (by releasing other factors such as endothelin or growth factors and together with these factors) stimulate smooth muscle cells. In addition, hemoglobin and other factors cause cytotoxicity and possibly trigger inflammatory response and generate cytokines. Platelet or leukocyte infiltration might lead to the production of 5-hydroxytryptamine, UTP, thromboxanes, and cytokines. In turn, the conditions fostered by these growth factors might stimulate the basilar artery, resulting in changes of P 2Y2 receptors.
Rat Double Hemorrhage Model of SAH
Developing a reliable model for rat SAH that closely parallels the pathogenesis of vasospasm in humans has proven difficult. 29 -36 Single hemorrhage rat models do not closely resemble the biphasic phenomena characteristic of SAH-induced vasospasm in large-animal models. Additionally, most single injection models have been conducted in acute studies-ie, those investigating only the initial acute constriction-while excluding the characteristic delayed spasm resulting in cerebral ischemia and the concomitant morbidity and mortality. 2 Other problems with previous models include the indirect evaluation of vasospasm (via angiogram or cerebral blood flow determination) or direct evaluation by gross observation. The illustrations of the small rat cerebral arteries proved to be difficult in these studies. Investigating the molecular changes associated with SAH-induced vasospasm requires a reliable rat model because most documented genes are from either rats or mice. A double hemorrhage model in rats has created vasospasm that resembles angiographically the time course of vasospasm in large-animal models. 37 Although massive single injections (0.5 mL) of blood have also been found to generate a similar time course for constriction, we found this method to be undesirable because it led to increased mortality (ie, high incidence of respiratory arrest due to extremely high inspiratory capacity, as noted in unpublished observations [R.C. Carpenter, BS, et al, unpublished data, 1999]).
According to our results, the profile of the cerebral vasospasm produced in this rat double hemorrhage model of SAH falls in the mild to moderate range, and we observed few severe vasospasms. The morphological changes as observed by TEM are consistent with those observed in most animal models (such as corrugation of the elastic lamina, which indicates vasoconstriction). Other features that have been described in humans (such as endothelial damage, smooth muscle migration, proliferation, necrosis, and apoptosis) were not observed to any appreciable extent. Therefore, this rat double hemorrhage model is more or less an experimental albeit atypical SAH model designed to parallel cerebral vasospasm observed in humans or in larger-animal models. Because this model did not successfully produce severe cerebral vasospasm, the molecular changes in P 2 receptor expression can only be analyzed within the context of an SAH model.
By examining the mRNA expression of P 2 receptors, this study demonstrates an upregulation of P 2Y receptors that might enhance a contractile response to extracellular ATP even at lower levels. The P 2X1 receptor might not be involved in chronic vasospasm, even though its role in acute vasospasm cannot be excluded. For several reasons, we recommend additional studies using larger animals (such as canines or primates) as models. First, these models replicate human vasospasm more closely (eg, severe contraction, endothelial damage). Second, separating the endothelial cells from the relatively larger cerebral arteries of canines or primates (as opposed to those of rodents) might prove useful (removal of endothelial cells is a crucial step in identifying the sources of different P 2 receptor mRNAs). Third, the protein expression of different P 2 receptors and the functional activities of these receptors during cerebral vasospasm need further examination.
Editorial Comment
The authors describe an interesting piece of vascular physiology, applied to subarachnoid hemorrhage in the rat. They are careful to point out the differences in (especially) morphology between vasospastic arteries in humans and in rats, but on balance this model appears to be at least as valid as the widely used dog double-hemorrhage model. This is useful, not only because rats are cheaper, easier to handle, and have less "pet appeal," but also because most of the genes known to play a role in vascular physiology have not been described in dogs, cats, or monkeys, but rather in rats and mice. Obviously, having less "pet appeal" does not absolve us from treating rats as humanely as possible, but the authors have 
